Nonparticipation in a Population-Based Trial to Increase Colorectal Cancer Screening

被引:21
|
作者
Green, Beverly B. [1 ,2 ,3 ]
Bogart, Andy [1 ]
Chubak, Jessica [1 ]
Vernon, Sally W. [7 ]
Morales, Leo S. [1 ]
Meenan, Richard T. [8 ,9 ]
Laing, Sharon S. [5 ]
Fuller, Sharon [1 ]
Ko, Cynthia [4 ]
Wang, Ching-Yun [6 ]
机构
[1] Univ Washington, Grp Hlth Res Inst, Seattle, WA 98101 USA
[2] Univ Washington, Grp Hlth Permanente, Seattle, WA 98101 USA
[3] Univ Washington, Dept Family Med, Seattle, WA 98101 USA
[4] Univ Washington, Div Gastroenterol, Seattle, WA 98101 USA
[5] Univ Washington, Hlth Promot Res Ctr, Seattle, WA 98101 USA
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[7] Univ Texas Houston, Sch Publ Hlth, Ctr Hlth Promot & Prevent Res, Houston, TX USA
[8] Ctr Hlth Res, Portland, OR USA
[9] Kaiser Permanente NW, Portland, OR USA
关键词
CLINICAL-TRIALS; UNDERREPRESENTED POPULATIONS; CARE; MANAGEMENT; INTERVENTION; RECRUITMENT; COMMUNITY; QUALITY; DESIGN; SYSTEM;
D O I
10.1016/j.amepre.2011.11.014
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Many trials have tested different strategies to increase colorectal cancer (CRC) screening. Few describe whether participants are representative of the population from which they are recruited. Purpose: To determine risk factors related to nonparticipation among patients enrolled in an integrated health plan and not up to date for CRC testing, in a trial to increase screening rates. Methods: Between July 2008 and October 2009, a total of 15,000 adults aged 50-74 years from 21 clinics in Washington State who were due for CRC screening were contacted. Nonparticipants were defined as English-speaking patients who did not engage in the call or refused participation while still potentially eligible. Log-binomial regression models were used to estimate the relative risk of nonparticipation. Analyses were completed between October 2010 and June 2011. Results: Patients who were nonwhite, had less education, used tobacco, had less continuity of care, and had lower rates of preventive care and cancer screening were more likely to be nonparticipants. Patients reporting never having received any type of CRC testing or screening were also more likely not to participate (62% of nonparticipants vs 46% of participants; adjusted RR = 1.58, 95% CI = 1.47, 1.70). Reasons for refusal included costs, risks of procedures, and not wanting their medical records reviewed. Conclusions: Patients eligible for but not participating in the trial were more likely to be from minority socioeconomic and racial groups and had behaviors that can negatively affect cancer outcomes. Additional efforts are needed to recruit patients who need CRC screening the most.
引用
收藏
页码:390 / 397
页数:8
相关论文
共 50 条
  • [41] Fecal Immunochemical Test (FIT) Characteristics by Sample Return Time in a Population-Based Colorectal Cancer Screening Trial
    van Roon, Aafke H.
    Hol, Lieke
    van Leerdam, Monique E.
    van Ballegooijen, Marjolein
    van Vuuren, Anneke
    van der Togt-van Leeuwen, Alexandra C.
    Reijerink, Jacqueline C.
    Habbema, J. D.
    Kuipers, Ernst J.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S133 - S133
  • [42] Are Fecal Immunochemical Test Characteristics Influenced by Sample Return Time? A Population-Based Colorectal Cancer Screening Trial
    van Roon, Aafke H. C.
    Hol, Lieke
    van Vuuren, Anneke J.
    Francke, Jan
    Ouwendijk, Martine
    Heijens, Angela
    Nagtzaam, Nicole
    Reijerink, Jacqueline C. I. Y.
    van der Togt, Alexandra C. M.
    van Ballegooijen, Marjolein
    Kuipers, Ernst J.
    van Leerdam, Monique E.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (01): : 99 - 107
  • [43] Time to Screening in the Systems of Support to Increase Colorectal Cancer Screening Trial
    Wang, Ching-Yun
    Tapsoba, Jean de Dieu
    Anderson, Melissa L.
    Vernon, Sally W.
    Chubak, Jessica
    Fuller, Sharon
    Green, Beverly B.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (08) : 1683 - 1688
  • [44] Incidence of Prostate Cancer After Termination of Screening in a Population-based Randomised Screening Trial
    Bergdahl, Anna Grenabo
    Holmberg, Erik
    Moss, Sue
    Hugosson, Jonas
    [J]. EUROPEAN UROLOGY, 2013, 64 (05) : 703 - 709
  • [45] Sensitivity of a colorectal cancer screening program based on a guaiac test: A population-based study
    Giai, Joris
    Exbrayat, Catherine
    Boussat, Bastien
    Poncet, Florence
    Du Colombier, Patrice Bureau
    Colonna, Marc
    Seigneurin, Arnaud
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2014, 38 (01) : 106 - 111
  • [46] Implementation of Universal Colorectal Cancer Screening for Lynch Syndrome: A Population-Based Study
    Sierra, Isabel
    Diaz-Algorri, Yaritza
    Maldonado, Valerie
    Alicea, Kimberly
    Rosado, Kathia
    Cruz-Correa, Marcia
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (02)
  • [47] Attitudes and knowledge of colorectal cancer and screening in Hong Kong: A population-based study
    Wong, BCY
    Chan, AO
    Wong, WM
    Hui, WM
    Kung, HF
    Lam, SK
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (01) : 41 - 46
  • [48] Molecular screening for hereditary nonpolyposis colorectal cancer:: A prospective, population-based study
    Percesepe, A
    Borghi, F
    Menigatti, M
    Losi, L
    Foroni, M
    Di Gregorio, C
    Rossi, G
    Pedroni, M
    Sala, E
    Vaccina, F
    Roncucci, L
    Benatti, P
    Viel, A
    Genuardi, M
    Marra, G
    Kristo, P
    Peltomäki, P
    de Leon, MP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (19) : 3944 - 3950
  • [49] The role of defensive information processing in population-based colorectal cancer screening uptake
    Clarke, Nicholas
    Hayes, Louise
    McQueen, Amy
    Gallagher, Pamela
    Kearney, Patricia M.
    McNamara, Deirdre
    O'Morain, Colm A.
    von Wagner, Christian
    Mooney, Therese
    Sharp, Linda
    [J]. CANCER, 2023, 129 (08) : 1253 - 1260
  • [50] Micro actions in colorectal cancer screening participation: a population-based survey study
    Siu Hing Lo
    Jo Waller
    Charlotte Vrinten
    Christian von Wagner
    [J]. BMC Cancer, 15